Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections
NCT ID: NCT00642785
Last Updated: 2008-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2008-01-31
2008-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis
NCT00736437
Iontophoretic Application of Acyclovir Gel to Treat Cold Sores
NCT00469300
Treatment of Herpes Labialis by Photodynamic Therapy
NCT04037475
Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis
NCT00230867
Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)
NCT00467662
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with active oral or genital HSV skin lesions
No interventions assigned to this group
2
Patients with a history of recurrent oral or genital HSV but without an active lesion at the time of treatment
No interventions assigned to this group
3
Patients with active shingles/zoster
No interventions assigned to this group
4
Patients with post herpetic neuralgia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Progressive Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Institute of Progressive Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
W John Martin, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute of Progressive Medicine
References
Explore related publications, articles, or registry entries linked to this study.
Martin WJ, Stoneburner J. Symptomatic relief of herpetic skin lesions utilizing an energy-based approach to healing. Exp Mol Pathol. 2005 Apr;78(2):131-4. doi: 10.1016/j.yexmp.2004.10.007. Epub 2005 Jan 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
071/081
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.